Effects of tertiary and quaternary derivatives of aminomethylenedioxyindenes on the mechanical and electrical activity of isolated guinea pig atria.
The 2-n-propyl- and 2-n-butyl-3-dimethylamino-5,6-methylenedioxyindenes (pr-MDI and bu-MDI, respectively) have been characterized as calcium antagonists with coronary dilating and antiarrhythmic properties. The quaternary 2-n-butyl-3-trimethylamino MDI (Q-bu-MDI) has been demonstrated to possess very potent antiarrhythmic activity in several model systems. In this investigation, the effects of pr-MDI, bu-MDI, and Q-bu-MDI on the mechanical and electrical behavior of isolated guinea pig atria were investigated. The tertiary pr- and bu-MDIs caused marked, concentration-dependent decreases in contractile force of stimulated left atria, while the Q-bu-MDI caused only a slight peak reduction in contractile force which was partially reversed at high concentrations. At a concentration of 3 x 10(-4) M, the pr- and bu-MDIs significantly depressed the frequency-force profile of stimulated left atria, and significantly decreased membrane excitability (as reflected by a significant increase in threshold voltage), while the Q-bu-MDI did not significantly alter either parameter. Spontaneous right atrial rate was only slightly depressed by the three MDI analogues at concentrations of 3 x 10(-5) M or less. At higher concentrations, the tertiary pr- and bu-MDIs were much more potent than the quaternary analogue in reducing atrial rate. The results indicate that Q-bu-MDI, the most potent antiarrhythmic analogue in the MDI series, exhibits significantly lesser deleterious effects on cardiac function than the tertiary MDIs.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D004594:Electrophysiology; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007192:Indenes / Q000494:pharmacology*; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects
D000889:Anti-Arrhythmia Agents; D007192:Indenes